Journal Guide

Journal of Cardiovascular Magnetic Resonance (JCMR), the official journal of the Society for Cardiovascular Magnetic Resonance, is an open access, online journal that publishes articles on all aspects of basic and clinical research on the design, development, manufacture, and evaluation of magnetic resonance methods applied to the cardiovascular system.

The Journal of Cardiovascular Medicine publishes original research articles, epidemiological studies, new methodological clinical approaches, design and goals of clinical trials, review articles, points of view, editorials and images in cardiovascular medicine.The Journal goes beyond the concept of evidence-based medicine at a regional level—critical commentary and case studies allow for variances between countries and regions. The Journal is designed to assist clinicians in making the best possible use of evidence-based medicine in primary and critical care, diagnosis and treatment decisions.For more information, visit www.jcardiovascularmedicine.com .

Official journal of the Preventive Cardiovascular Nurses Association and the Australasian Cardiovascular Nurses College, the Journal of Cardiovascular Nursing is one of the leading journals for advanced practice nurses in cardiovascular care, providing thorough coverage of timely topics and practical information. Each bimonthly issue addresses the physiologic, psychologic, and social needs of cardiovascular patients and their families in a variety of environments. All members of the Preventive Cardiovascular Nurses Association receive the journal as a benefit of membership.The Journal of Cardiovascular Nursing is recommended by the American Heart Association Council on Cardiovascular Nursing to its members. These members can receive a discount on subscription rates quoted above. Call customer service to verify discount at 1-800-638-3030. Visit: www.jcnjournal.com.

The Journal of Cardiovascular Pharmacology is the leading publication devoted exclusively to important advances in cardiovascular drug research and use. Each monthly issue provides the most up-to-date information on physiological and pharmacological bases of drug action, metabolism, drug interaction, side effects, and clinical results with both new and established drugs.Website: www.jcvp.org.

DON'T MISS A BEAT!Every informative issue of the Journal of Cardiovascular Pharmacology and Therapeutics (JCPT) offers cardiologists, clinical pharmacologists and researchers involved in disease relevant clinical and experimental investigations of newer cardiovascular drugs and other therapeutic options. Four times a year, JCPT examines and analyzes arenas such as: o Agents that Reduce Myocardial Infarct Size o Agents that Reduce Myocardial Remodeling o Angiotensin Converting Enzyme Inhibitors o Antihypertensive Therapy o Arrhythmias o Atrial Fibrillation o Beta-Blocker Therapies o Cardioembolic Stroke o Cardiomyopathy o Cardioprotective Agents o Cardiopulmonary Resuscitation o Cardiovascular Combination Therapies o Chronic Angina o Chronic Cardiac Ischemia o Congestive Heart Failure o Coronary Artery Disease o Coronary Revascularization o Heparin Therapies o Hypertension o Hypotension o Implantable Devices o Ischemic Heart Disease o Myocardial Infarction o Percutaneous Coronary Interventions o Peripheral Arterial Disease o Preconditioning/Postconditioning o Regenerative Cardiology o Stem Cell TherapyAmong the drug classes regularly evaluated are: ACE inhibitors * angiotensin receptor blockers * anti-anginals * anti-arrhythmics * anti-coagulants * anti-hypertensives * anti-thrombins * beta-blockers * calcium channel blockers * cardioprotective agents * cardiotonic agents * direct renin inhibitors * diuretics * fibrinolytic agents * heart rate modulats * plasminogen activators * QT prolonging drugs * statins * vasoconstrictor agents * and vasodilator agents.The journal features original articles, topical journal supplements, reviews, clinical and experimental investigations, and commentaries written by respected practitioners from all over the world.

Journal of Cardiovascular Translational Research (JCTR) is a premier journal in cardiovascular translational research.

JCTR is the journal of choice for authors seeking the broadest audience for emerging technologies, therapies and diagnostics, pre-clinical research, and first-in-man clinical trials. JCTR's intent is to provide a forum for critical evaluation of the novel cardiovascular science, to showcase important and clinically relevant aspects of the new research, as well as to discuss the impediments that may need to be overcome during the translation to patient care.

• Impact Factor: 3.062
• Authors receive a decision within 10 days, on average
• Fast OnlineFirst publication ahead of print

Journal of Cerebral Blood Flow & Metabolism stands at the interface between basic and clinical neurovascular research, and features timely and relevant research highlighting experimental, theoretical, and clinical aspects of brain circulation, metabolism and imaging. The journal is relevant to any physician or scientist with an interest in brain function, cerebrovascular disease, cerebral vascular regulation and brain metabolism, including neurologists, neurochemists, physiologists, pharmacologists, anesthesiologists, neuroradiologists, neurosurgeons, neuropathologists and neuroscientists.

The Journal of Clinical Hypertension is a peer-reviewed, monthly publication that serves family practitioners, internists, and cardiologists by providing objective, up-to-date information and practical recommendations on the treatment of hypertension. As newer studies are completed, they are summarized and critiqued. Reviews of recent publications in other journals and original papers that focus on the clinical management of hypertension are featured. JCH is the official journal of the American Society of Hypertension, Inc.For questions and information on submissions, contact: Phaedra Cress (pcress@wiley.com).

Because the scope of clinical lipidology is broad, the topics addressed by the Journal are equally diverse. Typical articles explore lipidology as it is practiced in the treatment setting, recent developments in pharmacological research, reports of treatment and trials, case studies, the impact of lifestyle modification, and similar academic material of interest to the practitioner. While preference is given to material of immediate practical concern, the science that underpins lipidology is forwarded by expert contributors so that evidence-based approaches to reducing cardiovascular and coronary heart disease can be made immediately available to our readers. Sections of the Journal will address pioneering studies and the clinicians who conduct them, case studies, ethical standards and conduct, professional guidance such as ATP and NCEP, editorial commentary, letters from readers, http://www.lipid.org/National Lipid Association (NLA) news and upcoming event information, as well as abstracts from the NLA annual scientific sessions and the scientific forums held by its chapters, when appropriate.

The Journal of Clinical Lipidology is NOW INCLUDED IN MEDLINE/PUBMED!

Electronic usage:
An increasing number of readers access the journal online via ScienceDirect, one of the world's most advanced web delivery systems for scientific, technical and medical information.

Average monthly article downloads for this journal: 6,615*
* Figure is a monthly average of full-text articles downloaded from ScienceDirect in 2014

Benefits to authors
We also provide many author benefits, such as free PDFs, a liberal copyright policy, special discounts on Elsevier publications and much more. Please click here for more information on our http://www.elsevier.com/wps/find/authorsview.authors/authorservicesauthor services.

Please see our http://www.elsevier.com/wps/find/journaldescription.cws_home/623308/authorinstructionsGuide for Authors for information on article submission. If you require any further information or help, please visit our support pages: http://support.elsevier.com

Journal of Endovascular Therapy, an official publication of the International Society of Endovascular Specialists, publishes peer-reviewed articles of interest to clinicians and researchers in the field of endovascular interventions.The Journal’s scope is multidisciplinary, representing all topics related to minimally invasive peripheral vascular diagnosis and treatment. Original clinical studies, experimental investigations, state-of-the-art reviews, rapid communications, case reports, technical notes, vascular images, editorials, and letters to the editors are published, as well as feature articles related to endovascular interventions.The Journal of Endovascular Therapy (formerly Journal of Endovascular Surgery) was established in 1994 as a forum for all physicians, scientists, and allied healthcare professionals who are engaged or interested in peripheral endovascular techniques and technology.The Journal seeks to support vascular specialists of all disciplines, improve patient care, and promote research and development by publishing peer-reviewed materials related to the field of peripheral endovascular interventions.

The Journal of Hypertension consistently attracts the most important and highly innovative papers from current research; our swift publication schedule ensures that these are published in the fastest time possible. In addition to primary papers from world-renowned experts, the Journal contains authoritative reviews and new guidelines or official statements on the management of hypertension.Also included are special reports, original short papers containing innovative and time-sensitive information. Its impressive impact factor rating of 5.132 (2008 SCI174; Journal Citation Reports) is a testament to its quality and standing in this field.International Society of Hypertension, European Society of Hypertension, and American Heart Association members are eligible for a discount on subscription rates.For more information, visit www.jhypertension.com.

The Journal of Interventional Cardiac Electrophysiology is an international publication devoted to fostering research in and development of interventional techniques and therapies for the management of cardiac arrhythmias. It is designed primarily to present original research studies and scholarly scientific reviews of basic and applied science and clinical research in this field. The Journal will adopt a multidisciplinary approach to link physical, experimental, and clinical sciences as applied to the development of and practice in interventional electrophysiology. The Journal will examine techniques ranging from molecular, chemical and pharmacologic therapies to device and ablation technology. Accordingly, original research in clinical, epidemiologic and basic science arenas will be considered for publication. Applied engineering or physical science studies pertaining to interventional electrophysiology will be encouraged. The Journal is committed to providing comprehensive and detailed treatment of major i

The Journal of Interventional Cardiology (JIC) is widely regarded as a must-read for the interventional cardiologist determined to stay current in diagnosing, investigating, and managing patients with cardiovascular disease. JIC publishes the most reliable and authoritative papers from the wealth of information that becomes available as new procedures and techniques develop.All material is peer-reviewed under the editorial direction of Cindy L Grines, MD and a prominent international editorial board. Six bimonthly issues contain original research, clinical investigation reports, trial reviews, special guest-edited issues, and a core curriculum to help readers prepare for the subspecialty board examination in interventional cardiology.

The Journal of Molecular and Cellular Cardiology publishes work advancing knowledge of the mechanisms responsible for both normal and diseased cardiovascular function. To this end papers are published in all relevant areas. These include (but are not limited to): structural biology; genetics; proteomics; morphology; stem cells; molecular biology; metabolism; biophysics; electrophysiology; pharmacology and physiology. Papers are encouraged with both basic and translational approaches. The journal is directed not only to basic scientists but also to clinical cardiologists who wish to follow the rapidly advancing frontiers of basic knowledge of the heart and circulation.US National Institutes of Health (NIH) voluntary posting ("Public Access") policyJournal of Molecular and Cellular Cardiology and Elsevier facilitate the author's response to the NIH Public Access Policy. For more details please see the Guide for authors